High-Dose Intravenous Immunoglobulin and Rituximab Treatment for Antibody-Mediated Rejection After Kidney Transplantation: A Cost Analysis
Autor: | Tanriover, B., Wright, S.E., Foster, S.V., Roush, K.S., Castillo-Lugo, J.A., Fa, K., Levy, F.L., Mejia, A. |
---|---|
Zdroj: | In Transplantation Proceedings 2008 40(10):3393-3396 |
Databáze: | ScienceDirect |
Externí odkaz: |